Vinorelbine: an overview
- 31 March 1996
- journal article
- review article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 22 (2), 127-142
- https://doi.org/10.1016/s0305-7372(96)90032-8
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- P-Glycoprotein mediated resistance to 5′-nor-anhydro-vinblastine (Navelbine®)Investigational New Drugs, 1995
- Evaluation of antitumor activity of navelbine (vinorelbine ditartrate) against human breast carcinoma xenografts based on its pharmacokinetics in nude miceAnti-Cancer Drugs, 1994
- Effective combination therapy of metastatic murine solid tumors with edatrexate and the vinca alkaloids, vinblastine, navelbine and vindesineCancer Chemotherapy and Pharmacology, 1994
- Combination effect of navelbine (vinorelbine ditartrate) with cisplatin against murine P388 leukemia and human lung carcinoma xenografts in miceAnti-Cancer Drugs, 1993
- Pharmacokinetics of vinorelbine in manEuropean Journal of Clinical Pharmacology, 1992
- Pharmacokinetics of navelbine after oral administration in cancer patientsCancer Chemotherapy and Pharmacology, 1991
- Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubulesInternational Journal of Cancer, 1990
- Experimental antitumor activity of 5′-nor-anhydrovinblastine navelbineCancer Letters, 1984
- 5'-Nor anhydrovinblastineTetrahedron, 1979
- Microtubule Formation in vitro in Solutions Containing Low Calcium ConcentrationsScience, 1972